Cargando…
Aberrant expression of select piRNA-pathway genes does not reactivate piRNA silencing in cancer cells
Germline genes that are aberrantly expressed in nongermline cancer cells have the potential to be ideal targets for diagnosis and therapy due to their restricted physiological expression, their broad reactivation in various cancer types, and their immunogenic properties. Among such cancer/testis gen...
Autores principales: | Genzor, Pavol, Cordts, Seth C., Bokil, Neha V., Haase, Astrid D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561285/ https://www.ncbi.nlm.nih.gov/pubmed/31110013 http://dx.doi.org/10.1073/pnas.1904498116 |
Ejemplares similares
-
Hierarchical length and sequence preferences establish a single major piRNA 3′-end
por: Stoyko, Daniel, et al.
Publicado: (2022) -
Cellular abundance shapes function in piRNA-guided genome defense
por: Genzor, Pavol, et al.
Publicado: (2021) -
Diversity of the piRNA pathway for nonself silencing: worm-specific piRNA biogenesis factors
por: Izumi, Natsuko, et al.
Publicado: (2014) -
To be or not to be a piRNA: genomic origin and processing of piRNAs
por: Le Thomas, Adrien, et al.
Publicado: (2014) -
Sensitized piRNA reporter identifies multiple RNA processing factors involved in piRNA-mediated gene silencing
por: Brown, Jordan, et al.
Publicado: (2023)